Oculus Innovative Sciences Announces Pricing of $3.4 Million Underwritten Public Offering Mar 18, 2016
Oculus Innovative Sciences Announces Proposed Underwritten Public Offering of Common Stock and Warrants Mar 17, 2016
Oculus Innovative Sciences to Present at the Roth Capital Partners 28th Annual Conference Mar 9, 2016
Oculus Innovative Sciences Receives European Approval to Market Lasercyn Indicated for Use Following Laser Skin Resurfacing Mar 3, 2016
Maxim Group Hosts Key Opinion Leaders Discussing “Breakthroughs in Dermatology” Relating to Products From Oculus Innovative Sciences Feb 18, 2016
Oculus Innovative Sciences to Present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference Feb 5, 2016
Oculus Innovative Sciences Announces Fiscal Third Quarter 2016 Financial Results and Conference Call Jan 21, 2016
Oculus Innovative Sciences Receives European CE Mark for New MucoClyns™ for First Responders Jan 14, 2016
